NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ennov

Ennov

Private
ParisHealthcare & Life Scienceshttps://en.ennov.com/

Last Round

Growth Equity

May 20, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ennov is a software company that provides a unified compliance platform for the life sciences industry, offering solutions for regulatory, quality, clinical, and pharmacovigilance processes.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Compliance & Risk, Quality Management, Document Management, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

life sciences softwareregulatory information managementRIMquality management systemQMSclinical trial managementCTMSpharmacovigilancePVelectronic document managementEDMScompliance softwareeTMFEDCvertical SaaSpharma techregulatory compliancebiotech software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ennov Comps

Public and private peers based on sector, stage, and business model.

Ennov comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ennov Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 20, 2026

Key People

Founding team and executive leadership

Olivier Pâris

Founder and CEO

Founding Team

Juan M.

Chief Technology Officer - DocShifter

Executive Team

Nicolas BREUGNON

Chief Financial Officer

Executive Team

Sebastien Rossi-Ferrari

Group Chief Financial Officer

Executive Team

Ennov Investors

Notable investors and investment history

Ennov investors
InvestorRounds
Windcrest PartnersSeed
ArdianGrowth Equity
Bregal SagemountGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Raised capital from Bregal Sagemount and Ardian.

  • Jan 2, 2026

    Monthly visitors increased 34% MoM, reaching 75.3K.

Ennov Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ennov Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ennov's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range310
Year Founded1999
Last FundingMay 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.